Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.

Samson A, Scott KJ, Taggart D, West EJ, Wilson E, Nuovo GJ, Thomson S, Corns R, Mathew RK, Fuller MJ, Kottke TJ, Thompson JM, Ilett EJ, Cockle JV, van Hille P, Sivakumar G, Polson ES, Turnbull SJ, Appleton ES, Migneco G, Rose AS, Coffey MC, Beirne DA, Collinson FJ, Ralph C, Alan Anthoney D, Twelves CJ, Furness AJ, Quezada SA, Wurdak H, Errington-Mais F, Pandha H, Harrington KJ, Selby PJ, Vile RG, Griffin SD, Stead LF, Short SC, Melcher AA.

Sci Transl Med. 2018 Jan 3;10(422). pii: eaam7577. doi: 10.1126/scitranslmed.aam7577.

2.

What is oncolytic virotherapy?

Cockle JV, Scott KJ.

Arch Dis Child Educ Pract Ed. 2018 Feb;103(1):43-45. doi: 10.1136/archdischild-2016-311922. Epub 2017 Jun 6. No abstract available.

PMID:
28588023
3.

Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion.

Cockle JV, BrĂ¼ning-Richardson A, Scott KJ, Thompson J, Kottke T, Morrison E, Ismail A, Carcaboso AM, Rose A, Selby P, Conner J, Picton S, Short S, Vile R, Melcher A, Ilett E.

Mol Ther Oncolytics. 2017 May 2;5:75-86. doi: 10.1016/j.omto.2017.04.002. eCollection 2017 Jun 16.

4.

Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.

Morgan JE, Hassan H, Cockle JV, Lethaby C, James B, Phillips RS.

Support Care Cancer. 2017 Jan;25(1):221-228. Epub 2016 Sep 11.

5.

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling.

Cockle JV, Rajani K, Zaidi S, Kottke T, Thompson J, Diaz RM, Shim K, Peterson T, Parney IF, Short S, Selby P, Ilett E, Melcher A, Vile R.

Neuro Oncol. 2016 Apr;18(4):518-27. doi: 10.1093/neuonc/nov173. Epub 2015 Sep 26.

6.

Cell migration in paediatric glioma; characterisation and potential therapeutic targeting.

Cockle JV, Picton S, Levesley J, Ilett E, Carcaboso AM, Short S, Steel LP, Melcher A, Lawler SE, BrĂ¼ning-Richardson A.

Br J Cancer. 2015 Feb 17;112(4):693-703. doi: 10.1038/bjc.2015.16. Epub 2015 Jan 27.

7.

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

Cockle JV, Picton SV, Melcher A.

CNS Oncol. 2013 Jul;2(4):307-10. doi: 10.2217/cns.13.25. No abstract available.

8.

Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications.

Cockle JV, Gopichandran N, Walker JJ, Levene MI, Orsi NM.

Reprod Sci. 2007 Oct;14(7):629-45. Review.

PMID:
18000225

Supplemental Content

Loading ...
Support Center